| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |